977 - 222 - 555 - 666


Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.


Tirzepatide works by mimicking the action of a hormone called GLP-1. It stimulates insulin release from the pancreas, reduces glucagon secretion, slows down gastric emptying, and promotes a feeling of fullness. These actions help lower blood sugar levels and promote weight loss.


Clinical trials have demonstrated that tirzepatide can lead to weight loss as a side effect. In these trials, participants with type 2 diabetes who received tirzepatide experienced greater reductions in body weight compared to those who received other diabetes medications or a placebo.

The weight loss observed with tirzepatide is believed to be a result of its effects on appetite regulation and satiety.


Tirzepatide has shown significant benefits in controlling blood sugar levels, reducing body weight, and lowering cardiovascular risks in people with type 2 diabetes.


Tirzepatide is administered as a subcutaneous injection (under the skin) once a week. The injection can be self-administered or given by a healthcare professional.


The most common side effects of Tirzepatide include gastrointestinal symptoms such as:

  • Nausea
  • Vomiting
  • Diarrhea

These side effects are usually mild to moderate and tend to improve over time.


Combining medications or interventions for weight loss purposes should be discussed with a healthcare professional. They can provide guidance on potential interactions, contraindications, and the most appropriate approach based on your individual circumstances.


Tirzepatide has been shown to improve blood sugar control within weeks of starting treatment. Maximum benefits are typically seen after several months of use.


If you qualify for a Mounjaro prescription and the drug is included in your insurance plan’s formulary, your monthly cost may vary.  Most branded weight loss medications require prior authorization for insurance to cover the cost. Your PlushCare physician and care team will reach out to your insurer on your behalf, and this process can take several business days. If you are denied the prior authorization or do not have health insurance, you may still purchase the medication at the total cash price. It is important to note that a type 2 diabetes diagnosis is usually required for insurance approval of this medication.

The makers of tirzepatide/Mounjaro (Lilly) are currently offering a co-pay savings card of $25 per month for specific individuals who qualify, which can be found on their website. Unfortunately, Mounjaro is expensive without insurance, ranging around $1000/month, depending on the pharmacy.


A limited number of patients may be eligible for the Mounjaro Saving Card, which allows certain patients to pay as little as $25 for a one-month or three-month supply of Mounjaro. You will likely need a type 2 diabetes diagnosis for eligibility. To find out if you are eligible, complete the enrollment form on the Mounjaro website.


Mounjaro helps control blood sugar and reduce hunger by releasing more insulin, less sugar, and slowing down digestion. This helps treat diabetes and can promote weight loss.


Keep in mind that currently Mounjaro (tirzepatide) is not technically FDA-approved for weight loss, but to treat diabetes.  But based on the results of SURMOUNT-1, if Mounjaro was approved for weight loss, it would easily become the most effective drug available. Given that it has two different mechanisms of action, it appears to have a greater effect on weight and blood sugar than GLP-1 agonist drugs alone, such as semaglutide or liraglutide, which are both currently FDA approved for sugar and weight control under different trade names. So when comparing tirzepatide vs. semaglutide, liraglutide, or other diabetes medicines, it seems to be much more effective.

Given that over half the patients on the 10 mg dose and 63% of those on the 15 mg dose lost more than 20% of their body weight, this number takes many past the weight loss achieved long term with surgical interventions such as the lap-band, and is within the typical ranges achieved long term with procedures such as the sleeve gastrectomy.


Tirzepatide can be used alone or in combination with other antidiabetic medications, such as metformin or insulin, depending on individual needs. However, specific combinations should be determined by a healthcare professional.


Tirzepatide is not a cure for diabetes. It is a medication that helps manage blood sugar levels and provides additional benefits for people with type 2 diabetes. Diabetes management involves a comprehensive approach, including lifestyle modifications and ongoing medical care.


No, Invigor Medical employs doctors licensed in all 50 states, and a medical consultation is included with each medical service. Each patient will receive a valid prescription, which is sent to the pharmacy to be filled.


Once you have enrolled for medical services with Invigor Medical, it usually takes 7-14 business days before items arrive at your home. This process includes an online medical consultation, prescription approval, the medication getting filled at the pharmacy, and the medication being sent to your home.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus tincidunt velit et libero ultrices congue. Nullam eu orci eu ex rutrum hendrerit. Ut enim justo, molestie sed ultricies id, ultrices eu ligula. Quisque nisl elit, fermentum a velit id, mollis volutpat lectus.


Most of the services that Invigor Medical offers are elective services. This means that most clients, if there are no restrictive contraindications, will be approved for the medications of their choice.

Helps You Feel Full Longer

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. After eating, cells in the gastrointestinal tract secrete GIP and GLP-1, which are both incretin hormones. These hormones increase insulin release from the pancreas and reduce glucose production in the liver. This lowers blood sugar and slows digestion, which helps you feel full longer. When you feel full longer, you eat less, which can lead to more than 20% weight loss and improved lipid metabolism.


To get Mounjaro for weight loss, you will need to speak to a board-certified doctor to begin the evaluation process and complete any necessary lab tests. Although Mounjaro can promote weight loss, it is a medication to treat type 2 diabetes.

Book an appointment with one of our board-certified doctors online to discuss if you can qualify for Mounjaro and begin the evaluation process.


Mounjaro is a new type 2 diabetes drug that can also help with weight loss. If you have diabetes and are struggling with weight loss, speak with one of our trusted, board-certified physicians online to discuss your health concerns and start the evaluation process for Mounjaro. This would include discussing your medical history and current medication and ordering baseline tests and studies to determine if you qualify for a Mounjaro prescription.

Wegovy and Saxenda are type 2 diabetes medications that are extremely effective for weight loss. They have now been approved for weight loss only without type 2 diabetes. Speak to one of our trusted, board-certified doctors about how Wegovy and Saxenda could be right for you.


You may be able to get a Mounjaro prescription online after meeting with a doctor to discuss your medical history and completing any necessary evaluations.

You can been the evaluation process for Mounjaro online with one of our board-certified doctors. If you have diabetes and are looking for weight management options, book an appointment with one our our top rated doctors online. After ordering any necessary lab tests and reviewing your results, if you qualify, your doctor can electronically send a prescription to your local pharmacy.


Although Mounjaro can promote weight loss, it has only been FDA-approved to treat type 2 diabetes.


Tirzepatide is what is known as a “dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist.”  This long and complicated name means it can do two things:

  1. Stimulate GLP-1 receptors in the body to both help control blood sugar and reduce hunger, promoting weight loss.

  2. Promote release of glucose-dependent insulinotropic polypeptide which helps modulate levels of a hormone called glucagon and improve insulin sensitivity of adipose (fat) tissue.


Mounjaro and Ozempic are in the same class of drugs, but work via different mechanisms. Mounjaro works on GIP and GLP-1 receptors, while Ozempic only works on GLP-1 receptors. Both are used to treat type 2 diabetes and can promote weight loss. To find out which one is right for you, speak to one of our board-certified doctors.

Scroll to top
× How can I help you?